- Home
- PEN vs PAYP Comparison
PEN vs PAYP Comparison
Compare PEN & PAYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEN | PAYP |
|---|---|---|
| Founded | 2004 | 2018 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 12.9B |
| IPO Year | 2015 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PEN | PAYP |
|---|---|---|
| Price | $319.34 | $14.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $360.14 | $25.54 |
| AVG Volume (30 Days) | 379.6K | ★ 834.1K |
| Earning Date | 05-12-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $1,403,665,000.00 | N/A |
| Revenue This Year | $14.34 | N/A |
| Revenue Next Year | $13.71 | $20.92 |
| P/E Ratio | $389.44 | ★ N/A |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $13.40 |
| 52 Week High | $362.41 | $24.89 |
Technical Indicators
Market Signals| Indicator | PEN | PAYP |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 30.36 |
| Support Level | $317.81 | N/A |
| Resistance Level | $322.24 | $23.11 |
| Average True Range (ATR) | 2.48 | 0.88 |
| MACD | 0.04 | -0.48 |
| Stochastic Oscillator | 14.25 | 14.55 |
Price Performance
Historical ComparisonAbout PEN Penumbra Inc.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
About PAYP PayPay Corporation American Depository Shares
PayPay is a fintech company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.